SUSRF(SUSRF)
SUSRF
No analyst ratings available
No analyst price targets available for SUSRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.01B | $1.13B | $1.27B | $1.46B | $1.64B |
| Low | $990M | $1.09B | $1.24B | $1.42B | $1.59B |
| High | $1.02B | $1.16B | $1.29B | $1.49B | $1.67B |
| EBITDA Avg | $257M | $290M | $325M | $374M | $419M |
| Low | $253M | $279M | $316M | $364M | $407M |
| High | $260M | $296M | $331M | $381M | $426M |
| EBIT Avg | $204M | $230M | $258M | $297M | $332M |
| Low | $201M | $221M | $251M | $289M | $323M |
| High | $207M | $235M | $262M | $302M | $338M |
| Net Income Avg | $101M | $143M | $181M | $251M | $298M |
| Low | $97M | $138M | $175M | $242M | $287M |
| High | $103M | $146M | $185M | $257M | $304M |
| EPS Avg | $1.98 | $2.81 | $3.55 | $4.92 | $5.83 |
| Low | $1.91 | $2.70 | $3.43 | $4.74 | $5.62 |
| High | $2.03 | $2.87 | $3.63 | $5.03 | $5.96 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 1 | 2 / 1 | 3 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $257M | $271M |
| Low | $251M | $265M |
| High | $269M | $284M |
| EBITDA Avg | $66M | $69M |
| Low | $64M | $68M |
| High | $69M | $73M |
| EBIT Avg | $52M | $55M |
| Low | $51M | $54M |
| High | $55M | $58M |
| Net Income Avg | $31M | $35M |
| Low | $30M | $34M |
| High | $33M | $37M |
| EPS Avg | $0.60 | $0.68 |
| Low | $0.58 | $0.66 |
| High | $0.64 | $0.72 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 |